FDA's PAT Initiative.
| Publicado en: | Pharmaceutical Technology Europe Vol. 16; no. 10; pp. 34 - 37 |
|---|---|
| Autor principal: | |
| Formato: | Journal Article |
| Publicado: |
MJH Life Sciences
Oct2004
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=108044057&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 108044057 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 17537967 5NG jtl: Pharmaceutical Technology Europe issn: 17537967 maglogo: N pubinfo: dt: Oct2004 vid: 16 iid: 10 pid: 54670 pub: MJH Life Sciences place: Cranbury, New Jersey artinfo: ui: 108044057 2011970446 108044057 ppf: 34 ppct: 3 formats: fmt: @attributes: type: P tig: atl: FDA's PAT Initiative. aug: au: Clark, Greg affil: Business Manager, Honeywell Process Solutions Life Science Competence Centre, Lovelace Road, Southern Industrial Area, Bracknell RG12 8WD, UK. sug: pubtype: Trade Publication doctype: Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|